OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The biological underpinnings of therapeutic resistance in pancreatic cancer
Gregory L. Beatty, Gregor Werba, Costas A. Lyssiotis, et al.
Genes & Development (2021) Vol. 35, Iss. 13-14, pp. 940-962
Open Access | Times Cited: 87
Gregory L. Beatty, Gregor Werba, Costas A. Lyssiotis, et al.
Genes & Development (2021) Vol. 35, Iss. 13-14, pp. 940-962
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 211
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 211
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 83
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 83
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 735-752
Open Access | Times Cited: 36
Seung Joon Park, Hee Chan Yoo, Eunyong Ahn, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 735-752
Open Access | Times Cited: 36
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Maruhen Amir Datsch Silveira, Steve Bilodeau, Tim F. Greten, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 583-597
Open Access | Times Cited: 38
Maruhen Amir Datsch Silveira, Steve Bilodeau, Tim F. Greten, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 583-597
Open Access | Times Cited: 38
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
Annalisa Comandatore, Benoît Immordino, Rita Balsano, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 286-286
Open Access | Times Cited: 29
Annalisa Comandatore, Benoît Immordino, Rita Balsano, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 286-286
Open Access | Times Cited: 29
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 628-628
Open Access | Times Cited: 21
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 628-628
Open Access | Times Cited: 21
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Max M. Wattenberg, Sarah Colby, Ignacio Garrido‐Laguna, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 1114-1129
Closed Access | Times Cited: 7
Max M. Wattenberg, Sarah Colby, Ignacio Garrido‐Laguna, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 1114-1129
Closed Access | Times Cited: 7
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
Yan Li, Renee B. Chang, Meredith L. Stone, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101397-101397
Open Access | Times Cited: 7
Yan Li, Renee B. Chang, Meredith L. Stone, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101397-101397
Open Access | Times Cited: 7
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic acid
Li Wang, Qunyan Yao, Xuerui Guo, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Li Wang, Qunyan Yao, Xuerui Guo, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients
Shouhui Yang, Wei Tang, Azadeh Azizian, et al.
Carcinogenesis (2022) Vol. 43, Iss. 12, pp. 1198-1210
Open Access | Times Cited: 27
Shouhui Yang, Wei Tang, Azadeh Azizian, et al.
Carcinogenesis (2022) Vol. 43, Iss. 12, pp. 1198-1210
Open Access | Times Cited: 27
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Gabriela Reyes‐Castellanos, Nadine Abdel Hadi, Alice Carrier
Cells (2022) Vol. 11, Iss. 3, pp. 426-426
Open Access | Times Cited: 24
Gabriela Reyes‐Castellanos, Nadine Abdel Hadi, Alice Carrier
Cells (2022) Vol. 11, Iss. 3, pp. 426-426
Open Access | Times Cited: 24
Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment
Keisuke Yamamoto, Dosuke Iwadate, Hiroyuki Kato, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4351-4351
Open Access | Times Cited: 24
Keisuke Yamamoto, Dosuke Iwadate, Hiroyuki Kato, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4351-4351
Open Access | Times Cited: 24
KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment
Eileen S. Carpenter, Padma Kadiyala, Ahmed M. Elhossiny, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 11, pp. 2497-2513
Open Access | Times Cited: 16
Eileen S. Carpenter, Padma Kadiyala, Ahmed M. Elhossiny, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 11, pp. 2497-2513
Open Access | Times Cited: 16
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 5
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 5
A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing
Anton Lahusen, Jierui Cai, Reinhold Schirmbeck, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Anton Lahusen, Jierui Cai, Reinhold Schirmbeck, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity
Yuan‐Na Lin, Marcel O. Schmidt, Ghada M. Sharif, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Yuan‐Na Lin, Marcel O. Schmidt, Ghada M. Sharif, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 22
DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer
Anna Brichkina, Miriam Ems, Роман В. Суезов, et al.
Gut (2024) Vol. 73, Iss. 10, pp. 1684-1701
Open Access | Times Cited: 4
Anna Brichkina, Miriam Ems, Роман В. Суезов, et al.
Gut (2024) Vol. 73, Iss. 10, pp. 1684-1701
Open Access | Times Cited: 4
Injectable hybrid hydrogels enable enhanced combination chemotherapy and roused anti-tumor immunity in the synergistic treatment of pancreatic ductal adenocarcinoma
Hao Zhou, Wei Wang, Zedong Cai, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Hao Zhou, Wei Wang, Zedong Cai, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
